M Isabel González-Tomé

Summary

Publications

  1. ncbi [Effectiveness of antiretroviral therapy in HIV-1 infected children. A cross-sectional study]
    María I González Tomé
    Servicio de Inmunodeficiencias, Hospital 12 de Octubre, Madrid, Spain
    An Pediatr (Barc) 62:32-7. 2005
  2. ncbi Gestational diabetes mellitus in a cohort of HIV-1 infected women
    M I González-Tomé
    Department of Immunodeficiencies, Hospital 12 de Octubre, Madrid, Spain
    HIV Med 9:868-74. 2008
  3. ncbi Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
    M Isabel González-Tomé
    Division of Immunodefiencies, Hospital 12 de Octubre, Madrid, Spain
    BMC Infect Dis 8:144. 2008
  4. ncbi Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients
    Claudia Palladino
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Pediatr Infect Dis J 29:563-6. 2010
  5. ncbi High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission
    Veronica Briz
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Pediatr Infect Dis J 31:1048-52. 2012

Collaborators

Detail Information

Publications5

  1. ncbi [Effectiveness of antiretroviral therapy in HIV-1 infected children. A cross-sectional study]
    María I González Tomé
    Servicio de Inmunodeficiencias, Hospital 12 de Octubre, Madrid, Spain
    An Pediatr (Barc) 62:32-7. 2005
    ..Such studies would be useful to determine patients' clinical and immunologic and virologic status, currently prescribed therapies and their associated toxicity...
  2. ncbi Gestational diabetes mellitus in a cohort of HIV-1 infected women
    M I González-Tomé
    Department of Immunodeficiencies, Hospital 12 de Octubre, Madrid, Spain
    HIV Med 9:868-74. 2008
    ..We undertook a prospective study to estimate the prevalence of gestational diabetes mellitus (GDM) and associated risk factors in a cohort of 669 HIV-1 infected women...
  3. ncbi Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
    M Isabel González-Tomé
    Division of Immunodefiencies, Hospital 12 de Octubre, Madrid, Spain
    BMC Infect Dis 8:144. 2008
    ..We report a case-series describing the effects in metabolic abnormalities in seven HIV-infected children, previously treated with protease inhibitor (PI) after switching to nevirapine...
  4. ncbi Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients
    Claudia Palladino
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Pediatr Infect Dis J 29:563-6. 2010
    ..After FPV/r treatment, 18 of 20 patients achieved undetectable HIV-RNA and 4 of 20 experienced adverse events. To date, FPV/r treatment has shown sustained antiviral response and immunologic improvement in our 20 patients...
  5. ncbi High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission
    Veronica Briz
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Pediatr Infect Dis J 31:1048-52. 2012
    ..We studied HIV coreceptor tropism in vertically HIV-infected children and adolescents with the objective of predicting the proportion of children and adolescents that could be treated with CCR5 (R5) antagonists...